|
|
| Line 4: |
Line 4: |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Argatroban<sup>®</sup> FDA Package Insert | | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Argatroban<sup>®</sup> FDA Package Insert |
|
| |
|
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban indications and usage|Indications and Usage]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban dosage and administration|Dosage and Administration]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban dosage forms and strengths|Dosage Forms and Strengths]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban contraindications|Contraindications]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban warnings and precautions|Warnings and Precautions]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban adverse reactions|Adverse Reactions]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban drug interactions|Drug Interactions]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban use in specific populations|Use in Specific Populations]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban overdosage|Overdosage]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban description|Description]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban clinical pharmacology|Clinical Pharmacology]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban nonclinical toxicology|Nonclinical Toxicology]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban clinical studies|Clinical Studies]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban how supplied storage and handling|How Supplied/Storage and Handling]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban patient counseling information|Patient Counseling Information]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban labels and packages|Labels and Packages]]
| |
| |-
| |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
| |
| |-
| |
| |}
| |
|
| |
| {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
| |
| ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Argatroban|{{fontcolor|#6C7B8B|Argatroban}}]]'''''
| |
| |-
| |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ZZZZZ<sup>®</sup> FDA Package Insert
| |
| |- | | |- |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban indications and usage|Indications and Usage]] | | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Argatroban indications and usage|Indications and Usage]] |